Re: Bonini et al.: Phase 2 randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis ( Ophthalmology. 2018;125:1332-1343) (2019)

First Author: Ting Darren Shu Jeng

Attributed to: Human Hybrid Antimicrobial Peptides for Corneal Infection: From Molecular Dynamic Simulation to In Vivo Animal Studies funded by MRC

No abstract provided

Type: Journal Article/Review

Volume: 126

Parent Publication: OPHTHALMOLOGY

Issue: 2

ISSN: 0161-6420